A new analysis suggests that some mutations that seem to occur in tumors might actually stem from infiltrating blood cells affected by myeloproliferative neoplasms.
The LOHGIC algorithm is currently being used to analyze tumor sequencing assay results as part of the Rutgers Cancer Institute's precision medicine program.
The researchers uncovered four Tourette disorder risk genes through exome sequencing of parent-child trios, and estimated there could be hundreds more.
The agency is funding genome sequencing and analysis centers to research the genomic basis of common diseases, as well as ongoing rare disease research.
